Am J Epidemiol 2003; 157:218-226.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Genital Human Papillomavirus Infection: Incidence and Risk Factors in a Cohort of Female University Students
1 Department of Epidemiology, University of Washington, Seattle, WA.
2 Department of Biostatistics, University of Washington, Seattle, WA.
3 Department of Pathology, University of Washington, Seattle, WA.
Incidence data on human papillomavirus (HPV) infection are limited, and risk factors for transmission are largely unknown. The authors followed 603 female university students in Washington State at 4-month intervals between 1990 and 2000. At each visit, a sexual and health questionnaire was completed and cervical and vulvovaginal samples were collected to detect HPV DNA. At 24 months, the cumulative incidence of first-time infection was 32.3% (95% confidence interval: 28.0, 37.1). Incidences calculated from time of new-partner acquisition were comparable for enrolled virgins and nonvirgins. Smoking, oral contraceptive use, and report of a new male sex partner—in particular, one known for less than 8 months before sex occurred or one reporting other partners—were predictive of incident infection. Always using male condoms with a new partner was not protective. Infection in virgins was rare, but any type of nonpenetrative sexual contact was associated with an increased risk. Detection of oral HPV was rare and was not associated with oral-penile contact. The data show that the incidence of HPV associated with acquisition of a new sex partner is high and that nonpenetrative sexual contact is a plausible route of transmission in virgins.
cohort studies; incidence; papillomavirus, human; sexual abstinence; sexual partners; sexually transmitted diseases
Abbreviations: Abbreviations: CI, confidence interval; HPV, human papillomavirus; HR, hazard ratio; PCR, polymerase chain reaction.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. K. Kjaer, K. Sigurdsson, O.-E. Iversen, M. Hernandez-Avila, C. M. Wheeler, G. Perez, D. R. Brown, L. A. Koutsky, E. H. Tay, P. Garcia, et al. A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions Cancer Prevention Research, October 1, 2009; 2(10): 868 - 878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lazarczyk, P. Cassonnet, C. Pons, Y. Jacob, and M. Favre The EVER Proteins as a Natural Barrier against Papillomaviruses: a New Insight into the Pathogenesis of Human Papillomavirus Infections Microbiol. Mol. Biol. Rev., June 1, 2009; 73(2): 348 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Green and D. Catlow Immunisation against human papilloma virus in a primary care trust: a report on the first three months of the national campaign Journal of Infection Prevention, May 1, 2009; 10(3): 112 - 115. [Abstract] [PDF]
|
|
|
|
 |
|
 B. N. Savani, S. Goodman, and A. J. Barrett Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation? Clin. Cancer Res., April 1, 2009; 15(7): 2219 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Goldstein, A. Goodman, M. G. del Carmen, and D. C. Wilbur Case 10-2009 -- A 23-Year-Old Woman with an Abnormal Papanicolaou Smear N. Engl. J. Med., March 26, 2009; 360(13): 1337 - 1344. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Galloway Human papillomaviruses: a growing field Genes & Dev., January 15, 2009; 23(2): 138 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Hutchinson and K. C. Klein Human papillomavirus disease and vaccines Am. J. Health Syst. Pharm., November 15, 2008; 65(22): 2105 - 2112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, P. J. Thompson, L. Ning, J. Killeen, L. Kamemoto, and B. Y. Hernandez Prevalence, Acquisition, and Clearance of Cervical Human Papillomavirus Infection among Women with Normal Cytology: Hawaii Human Papillomavirus Cohort Study Cancer Res., November 1, 2008; 68(21): 8813 - 8824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Steele, S. Collins, K. Wen, G. Ryan, C. Constandinou-Williams, and C. B. J. Woodman Measurement of the Humoral Immune Response following an Incident Human Papillomavirus Type 16 or 18 Infection in Young Women by a Pseudovirion-Based Neutralizing Antibody Assay Clin. Vaccine Immunol., September 1, 2008; 15(9): 1387 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Kim and S. J. Goldie Health and Economic Implications of HPV Vaccination in the United States N. Engl. J. Med., August 21, 2008; 359(8): 821 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ammatuna, L. Giovannelli, D. Matranga, S. Ciriminna, and A. Perino Prevalence of Genital Human Papilloma Virus Infection and Genotypes among Young Women in Sicily, South Italy Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2002 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Dempsey, A. Gebremariam, L. Koutsky, and L. Manhart Behavior in Early Adolescence and Risk of Human Papillomavirus Infection as a Young Adult: Results From a Population-Based Study Pediatrics, July 1, 2008; 122(1): 1 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Safaeian, M. Kiddugavu, P. E. Gravitt, S. J. Gange, J. Ssekasanvu, D. Murokora, M. Sklar, D. Serwadda, M. J. Wawer, K. V. Shah, et al. Determinants of Incidence and Clearance of High-Risk Human Papillomavirus Infections in Rural Rakai, Uganda Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1300 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, et al. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int. J. Epidemiol., June 1, 2008; 37(3): 536 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Vanslyke, J. Baum, V. Plaza, M. Otero, C. Wheeler, and D. L. Helitzer HPV and Cervical Cancer Testing and Prevention: Knowledge, Beliefs, and Attitudes Among Hispanic Women Qual Health Res, May 1, 2008; 18(5): 584 - 596. [Abstract] [PDF]
|
|
|
|
|
|
S. Gorander, T. Lagergard, M. Romanik, R. P. Viscidi, G. Martirosian, and J.-A. Liljeqvist Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland Clin. Vaccine Immunol., April 1, 2008; 15(4): 675 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Morita, E. Ramirez, and W. E. Trick Effect of a School-Entry Vaccination Requirement on Racial and Ethnic Disparities in Hepatitis B Immunization Coverage Levels Among Public School Students Pediatrics, March 1, 2008; 121(3): e547 - e552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Goon and C Sonnex Frequently asked questions about genital warts in the genitourinary medicine clinic: an update and review of recent literature Sex Transm Inf, February 1, 2008; 84(1): 3 - 7. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. J. Fleury, A. Touze, S. de Sanjose, F. X. Bosch, J. Klaustermeiyer, and P. Coursaget Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing Pseudovirions Clin. Vaccine Immunol., January 1, 2008; 15(1): 172 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rambout BScPhm, L. Hopkins MD MSc, B. Hutton MSc, and D. Fergusson PhD Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials Can. Med. Assoc. J., August 28, 2007; 177(5): 469 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Markowitz HPV Vaccines Prophylactic, Not Therapeutic JAMA, August 15, 2007; 298(7): 805 - 806. [Full Text] [PDF]
|
|
|
|
|
|
R. P. Insinga, E. J. Dasbach, E. H. Elbasha, K.-L. Liaw, and E. Barr Incidence and Duration of Cervical Human Papillomavirus 6, 11, 16, and 18 Infections in Young Women: An Evaluation from Multiple Analytic Perspectives Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 709 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Van de Velde, M. Brisson, and M.-C. Boily Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty Am. J. Epidemiol., April 1, 2007; 165(7): 762 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz Prevalence of HPV Infection Among Females in the United States JAMA, February 28, 2007; 297(8): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Daley, N. Liddon, L. A. Crane, B. L. Beaty, J. Barrow, C. Babbel, L. E. Markowitz, E. F. Dunne, S. Stokley, L. M. Dickinson, et al. A National Survey of Pediatrician Knowledge and Attitudes Regarding Human Papillomavirus Vaccination Pediatrics, December 1, 2006; 118(6): 2280 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vaccarella, R. Herrero, M. Dai, P. J.F. Snijders, C. J.L.M. Meijer, J. O. Thomas, P. T. Hoang Anh, C. Ferreccio, E. Matos, H. Posso, et al. Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2148 - 2153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R Schmiedeskamp and D. R Kockler Human Papillomavirus Vaccines Ann. Pharmacother., July 1, 2006; 40(7): 1344 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Winer, J. P. Hughes, Q. Feng, S. O'Reilly, N. B. Kiviat, K. K. Holmes, and L. A. Koutsky Condom use and the risk of genital human papillomavirus infection in young women. N. Engl. J. Med., June 22, 2006; 354(25): 2645 - 2654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Pichichero Prevention of Cervical Cancer Through Vaccination of Adolescents Clinical Pediatrics, June 1, 2006; 45(5): 393 - 398. [PDF]
|
|
|
|
 |
|
 J. J. Carter, G. C. Wipf, M. M. Madeleine, S. M. Schwartz, L. A. Koutsky, and D. A. Galloway Identification of human papillomavirus type 16 l1 surface loops required for neutralization by human sera. J. Virol., May 1, 2006; 80(10): 4664 - 4672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Burchell, H. Richardson, S. M. Mahmud, H. Trottier, P. P. Tellier, J. Hanley, F. Coutlee, and E. L. Franco Modeling the Sexual Transmissibility of Human Papillomavirus Infection using Stochastic Computer Simulation and Empirical Data from a Cohort Study of Young Women in Montreal, Canada Am. J. Epidemiol., March 15, 2006; 163(6): 534 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Weaver Epidemiology and Natural History of Genital Human Papillomavirus Infection J Am Osteopath Assoc, March 1, 2006; 106(suppl_1): S2 - S8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vaccarella, S. Franceschi, R. Herrero, N. Munoz, P. J.F. Snijders, G. M. Clifford, J. S. Smith, E. Lazcano-Ponce, S. Sukvirach, H.-R. Shin, et al. Sexual Behavior, Condom Use, and Human Papillomavirus: Pooled Analysis of the IARC Human Papillomavirus Prevalence Surveys. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Buck, P. M. Day, C. D. Thompson, J. Lubkowski, W. Lu, D. R. Lowy, and J. T. Schiller Human {alpha}-defensins block papillomavirus infection PNAS, January 31, 2006; 103(5): 1516 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, J. Jeronimo, M. Schiffman, R. Herrero, A. C. Rodriguez, M. C. Bratti, A. Hildesheim, S. Wacholder, L. R. Long, L. Neve, et al. Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution Cancer Res., January 15, 2006; 66(2): 1218 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schiffman and P. E Castle When to test women for human papillomavirus BMJ, January 14, 2006; 332(7533): 61 - 62. [Full Text] [PDF]
|
|
|
|
|
|
G. F. Sawaya A 21-Year-Old Woman With Atypical Squamous Cells of Undetermined Significance JAMA, November 2, 2005; 294(17): 2210 - 2218. [Full Text] [PDF]
|
|
|
|
|
|
B. Y. Hernandez, K. McDuffie, X. Zhu, L. R. Wilkens, J. Killeen, B. Kessel, M. T. Wakabayashi, C. C. Bertram, D. Easa, L. Ning, et al. Anal Human Papillomavirus Infection in Women and Its Relationship with Cervical Infection Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2550 - 2556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Sinclair, C. R. Woods, D. J. Kirse, and S. H. Sinal Anogenital and Respiratory Tract Human Papillomavirus Infections Among Children: Age, Gender, and Potential Transmission Through Sexual Abuse Pediatrics, October 1, 2005; 116(4): 815 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Orozco, J. J. Carter, L. A. Koutsky, and D. A. Galloway Humoral Immune Response Recognizes a Complex Set of Epitopes on Human Papillomavirus Type 6 L1 Capsomers J. Virol., August 1, 2005; 79(15): 9503 - 9514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Sasagawa, M Tani, H Yasuda, K A Khadijeh, A Sakai, T Fukae, T Ukita, H Yamazaki, S Satake, T Nakano, et al. Sexual behaviour and high risk human papillomavirus infections in Japanese women Sex Transm Inf, June 1, 2005; 81(3): 280 - 282. [Full Text] [PDF]
|
|
|
|
|
|
P. E. Castle, M. Schiffman, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, S. Wacholder, and A. T. Lorincz Semiquantitative Human Papillomavirus Type 16 Viral Load and the Prospective Risk of Cervical Precancer and Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1311 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Strickler, R. D. Burk, M. Fazzari, K. Anastos, H. Minkoff, L. S. Massad, C. Hall, M. Bacon, A. M. Levine, D. H. Watts, et al. Natural History and Possible Reactivation of Human Papillomavirus in Human Immunodeficiency Virus-Positive Women J Natl Cancer Inst, April 20, 2005; 97(8): 577 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J del Amo, C Gonzalez, J Losana, P Clavo, L Munoz, J Ballesteros, A Garcia-Saiz, M J Belza, M Ortiz, B Menendez, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain Sex Transm Inf, February 1, 2005; 81(1): 79 - 84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Viscidi, B. Snyder, S. Cu-Uvin, J. W. Hogan, B. Clayman, R. S. Klein, J. Sobel, and K. V. Shah Human Papillomavirus Capsid Antibody Response to Natural Infection and Risk of Subsequent HPV Infection in HIV-Positive and HIV-Negative Women Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 283 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, J. Pajanidi, J. Podistov, G. Chemeris, L. Sozaeva, E. Lipova, et al. Acquisition of High-Risk Human Papillomavirus Infections and Pap Smear Abnormalities among Women in the New Independent States of the Former Soviet Union J. Clin. Microbiol., February 1, 2004; 42(2): 505 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Hendricks RE: """GENITAL HUMAN PAPILLOMAVIRUS INFECTION: INCIDENCE AND RISK FACTORS IN A COHORT OF FEMALE UNIVERSITY STUDENTS""" Am. J. Epidemiol., November 1, 2003; 158(9): 927 - 927. [Full Text] [PDF]
|
|
|
|
|
|
L. A. Koutsky and R. L. Winer TWO AUTHORS REPLY Am. J. Epidemiol., November 1, 2003; 158(9): 927 - 928. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schiffman and S. K. Kjaer Chapter 2: Natural History of Anogenital Human Papillomavirus Infection and Neoplasia J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 14 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Giles Transmission of HPV Can. Med. Assoc. J., May 27, 2003; 168(11): 1391 - 1391. [Full Text] [PDF]
|
|
|
|
|
|
A. Lytwyn, J. Kaczorowski, A. Lorincz, and J. W. Sellors Transmission of HPV Can. Med. Assoc. J., May 27, 2003; 168(11): 1391 - 1391. [Full Text] [PDF]
|
|
|
|
|
|
RE: "GENITAL HUMAN PAPILLOMAVIRUS INFECTION: INCIDENCE AND RISK FACTORS IN A COHORT OF FEMALE UNIVERSITY STUDENTS" Am. J. Epidemiol., May 1, 2003; 157(9): 859 - 859. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Duggirala, M.-T. Cuddihy, J. E. Tammela, S. Lele, K. Odunsi, S. J. Schrag, A. Schuchat, J. Schulkin, C. B. Gambacorti, S. S. Yoo, et al. A Human Papillomavirus Type 16 Vaccine N. Engl. J. Med., April 3, 2003; 348(14): 1402 - 1405. [Full Text] [PDF]
|
|